Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
skin and connective tissue diseases | D017437 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
breast neoplasms | EFO_0003869 | D001943 | C50 |
gastrointestinal neoplasms | — | D005770 | C26.9 |
extravasation of diagnostic and therapeutic materials | — | D005119 | — |
Expiration | Code | ||
---|---|---|---|
pertuzumab, Perjeta, Genentech, Inc. | |||
2024-06-08 | Reference product excl. |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 25 | 22 | 1 | 3 | 55 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 2 | 6 | 3 | — | 1 | 10 |
Inflammatory breast neoplasms | D058922 | — | — | — | — | 3 | — | — | 3 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 2 | 1 | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 2 | 2 | — | — | 3 |
Colorectal neoplasms | D015179 | — | — | — | 2 | 1 | — | — | 2 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 1 | 1 | — | — | 2 |
Mucinous adenocarcinoma | D002288 | — | — | — | — | 2 | — | — | 2 |
Ductal carcinoma breast | D018270 | — | — | — | — | 2 | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | 2 | 1 | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 1 | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | — | 1 |
Unknown primary neoplasms | D009382 | — | — | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Pertuzumab |
INN | pertuzumab |
Description | Pertuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >4LLY:A,C|mutated Pertuzumab Fab heavy chain
EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRKAPGKGLEWVADVNPNSGGSIYNQEFKGRFTLSVDRSKNTLY
LQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSW
NSGALTSGVATGPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH
>4LLY:B,D|light chain Clambda
RIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQDKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQP
EDFATYYCQQYYIYPYTFGQGTKVEIKGQPKAAPSVTLFPPSSEELQANKATLVCYISDFYPGAVTVAWKADSSPVKAGV
ETTTPSKQSNNKYAAWSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTEC |
PDB | 1S78, 4LLU, 4LLW, 4LLY, 5VSH, 6OGE |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2007641 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06366 |
UNII ID | K16AIQ8CTM (ChemIDplus, GSRS) |